Ledger.Open graph →
SEC Form D · filed July 18, 2022

Kinaset Therapeutics, Inc

Offering
$41.0M
Sold
$28.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MEDFIELD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Tom King · Medfield, MADirectorBram Vanparys · Medfield, MADirectorKevin Bitterman · Medfield, MADirectorJamil Beg · Medfield, MADirectorFrazer Morgan · Medfield, MAExec · PromoterRoger Heerman · Medfield, MAExec · PromoterRobert Clarke · Medfield, MAExec · Director · PromoterChristopher Mcleod · Branford, CTDirectorDong Wang · Branford, CTDirectorVenkatasubramanian Viswanathan · Palo Alto, CAExec · PromoterQi Zhao · Branford, CTExec · PromoterAustin Sendek · Palo Alto, CADirectorCynthia Green · Branford, CTExec · Director · PromoterJay Teich · Branford, CTDirectorMario Dattilo · Naples, FLExec · Director · PromoterAndre Basbaum · San Diego, CAExec · PromoterFaith Barnett · San Diego, CADirectorMartha V. Shelley · LOS ANGELES, CADirectorJonah J. Lobel · Miami Beach, FLDirectorDigvijay Chauhan · Seattle, WADirectorNancy Cho · Seattle, WAExec · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗